NCT07167680 Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
| NCT ID | NCT07167680 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Spinal Cord Injuries (SCI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-09-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research team is conducting a study to determine if a fall prevention program designed specifically for people who use wheelchairs and scooters can help people better prevent and manage falls compared to the standard of care. This study will compare two groups of participants: 1. One group will use the iROLL-O+ app, which offers personalized fall prevention tools and strategies. 2. The other group will receive fall prevention information from a well-known program developed by the Centers for Disease Control and Prevention (CDC), called STEADI, which stands for Stopping Elderly Accidents, Deaths, and Injuries. This study includes adults living with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) who use a wheelchair or scooter every day. The research team aims to determine which approach is more effective in reducing falls and improving confidence in performing daily activities.
Eligibility Criteria
Inclusion Criteria: * 18 years old or older. * History of Multiple Sclerosis (MS) or Spinal Cord Injury (SCI). * Able to transfer independently or with minimal to moderate assistance. * Unable to walk 25 feet or more * Have experienced at least 1 fall in the past three years. * Have a care partner to assist the participant when practicing physical skills. * Have access to a smartphone/iPad. * Have a stable internet connection. Exclusion Criteria: * Multiple sclerosis exacerbation in the past 30 days, or are unable to remain in an upright position for an hour. * Impaired cognition (a score of 10 or above on the Short Blessed Test).
Contact & Investigator
Harshal Mahajan, Ph.D.
PRINCIPAL INVESTIGATOR
University of Illinois, Urbana-Champaign
Frequently Asked Questions
Who can join the NCT07167680 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries (SCI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07167680 currently recruiting?
Yes, NCT07167680 is actively recruiting participants. Contact the research team at ricela@illinois.edu for enrollment information.
Where is the NCT07167680 trial being conducted?
This trial is being conducted at Urbana, United States.
Who is sponsoring the NCT07167680 clinical trial?
NCT07167680 is sponsored by University of Illinois at Urbana-Champaign. The principal investigator is Harshal Mahajan, Ph.D. at University of Illinois, Urbana-Champaign. The trial plans to enroll 120 participants.